AKUS

Akouos, Inc. Common Stock
AKUS

Delisted

AKUS was delisted on the 30th of November, 2022.

Back to rankings
 

About: Akouos Inc is a genetic medicine company focused on developing gene therapies that restore, improve, and preserve hearing. The company is involved in developing potential genetic medicines for a variety of inner ear disorders.

Employees: 103

Healthcare Drug Manufacturers - General
Charts implemented using Lightweight Charts™